CasLoc logo
All Cases PTAB Litigations UPC Oppositions

UCB Inc. v. Zydus Pharmaceuticals (USA) Inc.

1:13-cv-01220

Overview

Case Number 1:13-cv-01220
Filing Date 2013-07-10
Status Terminated
Termination Date 2016-09-02
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Cadila Healthcare Ltd. Operating Company

Represented By

1 Attorneys Listed

Francis J. Murphy , Jr.

Murphy, Spadaro & Landon

Tel: +1 (302) 472-8100

Murphy, Spadaro & Landon, 1011 Centre Road

Zydus Pharmaceuticals (USA) Inc. Operating Company

Represented By

5 Attorneys Listed

Francis J. Murphy , Jr.

Murphy, Spadaro & Landon

Tel: +1 (302) 472-8100

Murphy, Spadaro & Landon, 1011 Centre Road

Timothy F. Peterson

Email: tpeterson@lockelord.com

Michael J. Gaertner

Email: mgaertner@lockelord.com

David B. Abramowitz

Email: dabramowitz@lockelord.com

Andrea L. Wayda

UNDELIVERABLE EMAIL 5/15/2020

Plaintiff

Harris FRC Corporation NPE (Individual / Inventor)

Represented By

2 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Research Corporation Technologies Inc. NPE (Patent Assertion Entity)

Represented By

2 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

UCB Pharma GmbH NPE (Individual / Inventor)

Represented By

2 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

UCB Inc. Operating Company

Represented By

2 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

No Co-Pending Disputes Detected in Current Index

There are no other active filings for this patent family across our indexed PTAB, U.S. Court, UPC, or EPO databases.

Patents Involved

No asserted patent numbers detected in initial docket filings yet.

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

1

Dispositive

0

Granted

0

Denied

0

Pending / Review

1

Motions by Category

Claim Construction / Markman Filing 1

Key Dispositive Motions & Rulings

Claim Construction / Markman Filing Pending / Under Review
SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. These actions are consolidated for all purposes and all papers shall b...
Entry #23 • 2014-02-10 Document →

Docket Entries

(38 total)
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed against Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1326018.) - filed by UCB Pharma GmbH, UCB Inc., Research Corporation Technologies Inc., Harris FRC Corporation. (Attachments: # 1 Exhibit A-B, # 2 Civil Cover Sheet)(cla, ) (Entered: 07/11/2013)

Entry #1 • 2013-07-10
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (cla, ) (Entered: 07/11/2013)

Entry #2 • 2013-07-10
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 6/12/13. Date of Expiration of Patent: 3/17/22.Thirty Month Stay Deadline: 12/12/2015. (cla, ) (Entered: 07/11/2013)

Entry #3 • 2013-07-10
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE 38,551;. (cla, ) (Entered: 07/11/2013)

Entry #4 • 2013-07-10
1

Disclosure Statement pursuant to Rule 7.1 filed by Harris FRC Corporation, Research Corporation Technologies Inc., UCB Inc., UCB Pharma GmbH identifying Corporate Parent UCB S.A., Other Affiliate UCB Holdings Inc., Other Affiliate UCB Lux S.A., Other Affiliate Fipar US Inc., Other Affiliate Medeva Ltd. for UCB Inc.; Corporate Parent UCB GmbH, Other Affiliate UCB S.A., Other Affiliate UCB Finance N.V. for UCB Pharma GmbH. (cla, ) (Entered: 07/11/2013)

Entry #5 • 2013-07-10
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc